Novartis is set to review its advisers in the US and Europe following the completion of its $40bn (£25bn) takeover of Alcon earlier this year.

The review will be led by incoming general counsel Felix Ehrat, who is joining the pharma giant next month from Swiss law firm Baer & Karrer, where he was senior partner.